Deposition and passage of transthyretin through the blood-nerve barrier in recipients of familial amyloid polyneuropathy livers. (Q47662219)

4 February 2018

title

Deposition and passage of transthyretin through the blood-nerve barrier in recipients of familial amyloid polyneuropathy livers. (English)

1 reference

4 February 2018

author

Mónica M. Sousa

1

1 reference

4 February 2018

Maria João Saraiva

11

1 reference

4 February 2018

Rui Perdigoto

object named as

Rui Perdigoto

6

0 references

Rui Fernandes

object named as

Rui Fernandes

3

0 references

author name string

José Ferrão

2

1 reference

4 February 2018

António Guimarães

4

1 reference

4 February 2018

José B Geraldes

5

1 reference

4 February 2018

Luís Tomé

7

1 reference

4 February 2018

Oscar Mota

8

1 reference

4 February 2018

Luís Negrão

9

1 reference

4 February 2018

Alexandre Linhares Furtado

10

1 reference

4 February 2018

publication date

1 July 2004

1 reference

4 February 2018

published in

Laboratory Investigation

1 reference

4 February 2018

volume

84

1 reference

4 February 2018

issue

7

1 reference

4 February 2018

page(s)

865-873

1 reference

4 February 2018

https://scigraph.springernature.com/pub.10.1038/labinvest.3700107

exact match

0 references

cites work

A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700107

Familial amyloid polyneuropathy: an electron microscope study of the peripheral nerve in five cases. II. Nerve fibre changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700107

Amyloid fibril protein in familial amyloidotic polyneuropathy, Portuguese type. Definition of molecular abnormality in transthyretin (prealbumin).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700107

Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700107

Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700107

Improvement in the polyneuropathy associated with familial amyloid polyneuropathy after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700107

Congo red as a stain for fluorescence microscopy of amyloid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700107

Exposure of cryptic epitopes on transthyretin only in amyloid and in amyloidogenic mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700107

Nodular cutaneous amyloidosis and carpal tunnel syndrome due to the amyloidogenic transthyretin His 114 variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700107

Peripheral nerve changes in amyloid neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700107

Neurodegeneration in familial amyloid polyneuropathy: from pathology to molecular signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700107

Long-term follow-up of survival of liver transplant recipients with familial amyloid polyneuropathy (Portuguese type)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700107

No Evidence Of De Novo Amyloidosis In Recipients Of Domino Liver Transplantation: 12 To 40 (Mean 24) Month Follow-Up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700107

Dissociated sensation in amylidosis. Compound action potential, quantitative histologic and teased-fiber, and electron microscopic studies of sural nerve biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700107

7 January 2021

Familial amyloid polyneuropathy: receptor for advanced glycation end products-dependent triggering of neuronal inflammatory and apoptotic pathways.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700107

7 January 2021

Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-met30)

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700107

7 January 2021

Partial-liver transplantation to treat familial amyloid polyneuropathy: follow-up of 11 patients

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700107

7 January 2021

Maximum sharing of cadaver liver grafts composite split and domino liver transplants

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700107

7 January 2021

Clinical improvement after liver transplantation for type I familial amyloid polyneuropathy

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700107

7 January 2021

Peripheral nerves regenerated in familial amyloid polyneuropathy after liver transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700107

7 January 2021

The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700107

7 January 2021

Results of liver transplantation for familial amyloid polyneuropathy type I in Brazil

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700107

7 January 2021

Sequential liver transplantation

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700107

7 January 2021

Skin involvement in familial amyloidotic polyneuropathy

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700107

7 January 2021

Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: implications for amyloid fibrillogenesis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700107

7 January 2021

10.1038/LABINVEST.3700107

Identifiers

DOI

1 reference

4 February 2018

PubMed ID

15122304

1 reference

4 February 2018